Biogen Inc. buy Royal Bank of Canada
Start price
29.05.24
/
50%
€195.00
Target price
29.05.25
€292.88
Performance (%)
7.38%
Price
12:32
€209.40
Summary
This prediction is currently active. With a performance of 7.38%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 29.05.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | 1.499% | 1.499% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat